| 18F-FDG PET/CT of transitional cell carcinoma. | |
| | |
MedLine Citation:
|
PMID: 19933624 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: The objective of this article is to provide a practical illustrated review of PET/CT in the imaging evaluation of transitional cell carcinoma. CONCLUSION: Local evaluation of the primary tumor in patients with transitional cell carcinoma on PET is often limited by the obscuring effect of excreted FDG, but assessment of metabolic activity may still be possible through close correlation with CT images. PET/CT may also be helpful in the detection of disease outside the bladder at nodal or more distant sites and in the assessment of recurrent disease. |
| | |
Authors:
|
Vivek V Patil; Zhen J Wang; Richard A Sollitto; Kai-Wen Chuang; Badrinath R Konety; Randy A Hawkins; Fergus V Coakley |
Related Documents
:
|
15805874 - Positron-emission tomography for surveillance of head and neck cancer. 11169064 - 18f-fluorodeoxyglucose (fdg)-pet features of focal nodular hyperplasia (fnh) of the liver. 19520214 - Impact of integrated pet/ct in the staging of oesophageal cancer: a uk population-based... 17224294 - Role for positron emission tomography in skeletal diseases. 12790444 - Coregistration of diffuse optical spectroscopy and magnetic resonance imaging in a rat ... 959524 - Brain scanning with the anger multiplane tomographic scanner as a second examination ev... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Review |
Journal Detail:
|
Title: AJR. American journal of roentgenology Volume: 193 ISSN: 1546-3141 ISO Abbreviation: AJR Am J Roentgenol Publication Date: 2009 Dec |
Date Detail:
|
Created Date: 2009-11-25 Completed Date: 2010-01-07 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7708173 Medline TA: AJR Am J Roentgenol Country: United States |
Other Details:
|
Languages: eng Pagination: W497-504 Citation Subset: AIM; IM |
Affiliation:
|
Department of Radiology, University of California San Francisco, San Francisco, CA 94143-0628, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Carcinoma, Transitional Cell
/
pathology,
radiography*,
radionuclide imaging* Fluorodeoxyglucose F18 / diagnostic use* Humans Image Enhancement / methods Lymphatic Metastasis / pathology, radiography, radionuclide imaging Neoplasm Recurrence, Local / pathology, radiography, radionuclide imaging Neoplasm Staging / methods Positron-Emission Tomography / methods* Radiopharmaceuticals / diagnostic use* Tomography, X-Ray Computed / methods* Urinary Bladder Neoplasms / pathology, radiography*, radionuclide imaging* |
| Grant Support | |
ID/Acronym/Agency:
|
1 T32 EB001631/EB/NIBIB NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimick...
Next Document: CT and MRI of spinal neuroarthropathy.